Report Highlights
The global market for assistive technology should grow from $44.1 billion in 2021 to $57.9 billion by 2026 with a compound annual growth rate (CAGR) of 5.6% for the period of 2021-2026.
Report Includes
- 42 data tables and 62 additional tables
- An updated review of the global market for disabled and elderly assistive technologies (AT)/assistive devices
- Analyses of the global market trends, with historic data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the overall market size in dollar value terms, and corresponding market share analysis by product type and geographic region
- Technology assessment of the key drivers and constraints that will shape the market for disabled and elderly assistive technologies over the next ten years
- Coverage of major product types and applications, both in the commercial and developmental phase
- Identification of the major stakeholders and analysis of their competitive landscape based on recent developments and segmental revenues
- Review of various new premarket approvals (PMA) and 510(k) clearances received in the disabled and elderly assistive technology and devices market between Jan. 2018 to Sept. 2021
- Insight into the recent industry structure, current competitive scenario, R&D activities, regulatory and legislative issues, and license agreements currently focused on disabled and elderly assistive technologies and devices market
- Company profiles of the key industry players, including Cochlear Ltd., Invacare Corp., Savaria Corp., Sonova Holdings AG, GN Group and ConvaTec
Report Scope
The report focuses on the global market for the various types of assistive devices that are on the market to enable disabled and elderly persons to move about, see, hear, speak, dress themselves and perform many other everyday activities as “normally” as possible. It provides a detailed description of the different types of disabled and elderly assistive technologies (mobility aids, access aids, beds, seating systems and ergonomic aids, daily living aids, communication aids, medical/personal monitoring aids, vision and reading aids, computer access aids, and environmental aids) and their current and projected market potential.
The mobility aids market is segmented in wheelchairs and scooters, ambulatory aids, vehicle conversions and navigation aids. Access aids market is segmented in residential/home elevators, transfer lifts, wheelchair lifts, stair lifts/climbers, accessible baths and showers, and door openers. Daily living aids market is divided in incontinence and ostomy products, toileting aids and other daily living aids. Communication aids market is segmented in hearing and listening aids, and speech and writing aids.
The report provides market revenue for each geographical segments, North America, Europe, Asia-Pacific and Rest of the World (RoW). The report’s detailed analysis allows for an in-depth understanding of the market, competitive environment, market background, technological advancement, drivers, restraints and market growth trends. This report does not cover physical therapy and exercise equipment designed for the elderly and disabled.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
- Metal-organic Frameworks: Global Markets (AVM200B)
- Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets (PHM204C)
- Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045J)
- Surgical Equipment: Technologies and Global Markets (HLC154C)
Report Highlights
The U.S. market for assistive technologies is projected to grow from $40.6 billion (including eyeglasses and contact lenses) in 2014 to $43.1 billion in 2015 and $58.3 billion in 2020, with a compound annual growth rate (CAGR) of 6.2% between 2015 and 2020.
Report Includes
- An overview of the markets for disabled and elderly assistive technologies, which encompasses a broad range of devices, from "low-tech" products such as eyeglasses and large-print books to technologically sophisticated products such as voice synthesizers, Braille readers, and wireless monitoring devices.
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
- Discussion concerning the markets dynamics, specifically drivers, constraints and opportunities.
- Examination of the industry structure, competition, and market shares.
- Analysis of major product types and applications, both commercial and developmental.
- Comprehensive company profiles of major players.
Report Highlights
The U.S. market for assistive technologies is projected to grow from nearly $43.4 billion (including eyeglasses and contact lenses) in 2012 to $45.9 billion in 2013 and nearly $60.5 billion in 2018, a compound annual growth rate (CAGR) of 5.7% between 2013 and 2018.
Report Includes
- An overview of the U.S. market for disabled and elderly assistive technologies, which encompasses a broad range of devices, from "low-tech" products such as eyeglasses and large-print books to technologically sophisticated products such as voice synthesizers, Braille readers, and wireless monitoring devices.
- Analyses of market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Discussion of market drivers and constraints.
- Examination of the industry structure, competition, and market shares.
- Comprehensive company profiles of major players.
Report Highlights
The U.S. market for assistive technologies is projected to grow from $39.5 billion (including eyeglasses and contact lenses) in 2010 to $41.1 billion in 2011 and $55 billion in 2016, a compound annual growth rate (CAGR) of 6% between 2011 and 2016.
Report Highlights
- The U.S. market for assistive technology is expected to be worth $38.2 billion in 2008, up from $36.4 billion in 2007. This should increase to $49.3 billion in 2013, a compound annual growth rate (CAGR) of 5.3%.
- The vision and reading aids segment dominates the market, generating $24.9 billion in 2007 and an estimated $26.1 billion in 2008 and $33.3 billion in 2013, a CAGR of 5.0%.
- The communication aids segment is worth $4.4 billion in 2007. This should increase slightly in 2008 and reach $5.4 billion in 2013, for a CAGR of 4.0%.
Report Highlights
-
The U.S. market for assistive technologies is projected to rise from $30.7 billion in 2005 to $39.4 billion in 2010, an AAGR (average annual growth rate) of 5.2%.
-
The market excluding eyeglasses and contacts is estimated at $8.7 billion and rising to $11.3 billion in 2010, an AAGR of 5.4%.
-
The largest market segments after vision and reading aids are daily living aids, mobility aids (expected to drop from 7.2% of the market to 5.7% in 2010) and communication aids.
-
Access aids appear poised to increase their market share from 2.9% in 2004 to 4.3% in 2010.
Related Reports
Elder Care Services and Assistive Devices: Global Markets
The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Antiaging Products and Services: The Global Market
The global market for antiaging products and services is estimated to increase from $74.8 billion in 2022 to reach $93.2 million by 2027, at a compound annual growth rate (CAGR) of 4.5% from 2022 through 2027.
Home Medical Equipment: Technologies and Global Markets
The global market for home medical equipment (HME) is estimated to increase from $43.3 billion in 2022 to $64.8 billion by 2027, at a compound annual growth rate (CAGR) of 8.4% from 2022 through 2027.
Bionics: Technologies and Global Markets
The global bionic devices market should reach $6.2 billion by 2024 and $11.3 billion by 2029 from $3.7 billion in 2019 at compound annual growth rates (CAGRs) of 11.1% and 12.8% for the period of 2019 to 2024 and 2024 to 2029, respectively.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More